cached image

Brian M. Cox - Publications

Affiliations: 
Uniformed Services University of the Health Sciences, Bethesda, MD 
Area:
Opioid pharmacology
Website:
http://www.usuhs.mil/pha/bcox.html

136 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shepard RD, Gouty S, Kassis H, Berenji A, Zhu W, Cox BM, Nugent FS. Targeting histone deacetylation for recovery of maternal deprivation-induced changes in BDNF and AKAP150 expression in the VTA. Experimental Neurology. PMID 30102916 DOI: 10.1016/j.expneurol.2018.08.002  0.84
2017 Barbacci DC, Roux A, Muller L, Jackson SN, Post J, Baldwin K, Hoffer B, Balaban C, Gouty S, Cox BM, Woods AS. Mass Spectrometric Imaging of Ceramides Tracks Therapeutic Response in Traumatic Brain Injury. Acs Chemical Neuroscience. PMID 28745861 DOI: 10.1021/acschemneuro.7b00189  0.84
2017 Bogoslovsky T, Bernstock JD, Bull G, Gouty S, Cox BM, Hallenbeck JM, Maric D. Development of a systems-based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury. Journal of Neuroscience Research. PMID 28463430 DOI: 10.1002/jnr.24054  0.84
2016 Authement ME, Langlois LD, Kassis H, Gouty S, Dacher M, Shepard RD, Cox BM, Nugent FS. Morphine-induced synaptic plasticity in the VTA is reversed by HDAC inhibition. Journal of Neurophysiology. jn.00238.2016. PMID 27306674 DOI: 10.1152/jn.00238.2016  0.84
2016 Roux A, Muller L, Jackson SN, Post J, Baldwin K, Hoffer B, Balaban CD, Barbacci D, Schultz JA, Gouty S, Cox BM, Woods AS. Mass spectrometry imaging of rat brain lipid profile changes over time following traumatic brain injury. Journal of Neuroscience Methods. PMID 26872743 DOI: 10.1016/j.jneumeth.2016.02.004  1
2015 Santhappan R, Crowder AT, Gouty S, Cox BM, Côté TE. Mu Opioid Receptor Activation Enhances Regulator of G protein Signaling 4 Association with the Mu Opioid Receptor/G protein Complex in a GTP-Dependent Manner. Journal of Neurochemistry. PMID 26119705 DOI: 10.1111/jnc.13222  1
2015 Authement ME, Kodangattil JN, Gouty S, Rusnak M, Symes AJ, Cox BM, Nugent FS. Histone Deacetylase Inhibition Rescues Maternal Deprivation-Induced GABAergic Metaplasticity through Restoration of AKAP Signaling. Neuron. 86: 1240-52. PMID 26050042 DOI: 10.1016/j.neuron.2015.05.024  1
2015 Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR Review 9. British Journal of Pharmacology. 172: 317-23. PMID 24528283 DOI: 10.1111/bph.12612  1
2013 Woods AS, Colsch B, Jackson SN, Post J, Baldwin K, Roux A, Hoffer B, Cox BM, Hoffer M, Rubovitch V, Pick CG, Schultz JA, Balaban C. Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury. Acs Chemical Neuroscience. 4: 594-600. PMID 23590251 DOI: 10.1021/cn300216h  1
2013 Dacher M, Gouty S, Dash S, Cox BM, Nugent FS. A-kinase anchoring protein-calcineurin signaling in long-term depression of GABAergic synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2650-60. PMID 23392692 DOI: 10.1523/JNEUROSCI.2037-12.2013  1
2013 Cox B, Han JS, Dingledine R. Avram Goldstein: the founder of molecular pharmacology. Molecular Pharmacology. 83: 720-2. PMID 23329728 DOI: 10.1124/mol.112.084640  1
2013 Cox BM. Recent developments in the study of opioid receptors. Molecular Pharmacology. 83: 723-8. PMID 23249538 DOI: 10.1124/mol.112.083279  1
2010 Gouty S, Brown JM, Rosenberger J, Cox BM. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons. Neuroscience. 169: 269-78. PMID 20417255 DOI: 10.1016/j.neuroscience.2010.04.033  1
2009 Di Benedetto M, Cavina C, D'Addario C, Leoni G, Candeletti S, Cox BM, Romualdi P. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats. Neuropharmacology. 56: 761-7. PMID 19162046 DOI: 10.1016/j.neuropharm.2008.12.009  1
2007 Cox BM. Torald Sollmann's studies of mustard gas. Molecular Interventions. 7: 124-8. PMID 17609517 DOI: 10.1124/mi.7.3.1  1
2006 Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG, Hanson GR, Hauser KF, Ho WZ, Hong JS, Major EO, Maragos WF, Masliah E, McArthur JC, Miller DB, et al. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 351-99. PMID 18040811 DOI: 10.1007/s11481-006-9048-9  1
2006 Brown JM, Gouty S, Iyer V, Rosenberger J, Cox BM. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. Journal of Neurochemistry. 98: 495-505. PMID 16749908 DOI: 10.1111/j.1471-4159.2006.03902.x  1
2005 Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, et al. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9591-601. PMID 16237164 DOI: 10.1523/JNEUROSCI.2546-05.2005  1
2005 Cox BM. Agonists at mu-opioid receptors spin the wheels to keep the action going. Molecular Pharmacology. 67: 12-4. PMID 15496509 DOI: 10.1124/mol.104.008433  1
2004 Cox BM, Crowder AT. Receptor domains regulating mu opioid receptor uncoupling and internalization: relevance to opioid tolerance. Molecular Pharmacology. 65: 492-5. PMID 14978226 DOI: 10.1124/mol.65.3.492  1
2004 Witta J, Palkovits M, Rosenberger J, Cox BM. Distribution of nociceptin/orphanin FQ in adult human brain. Brain Research. 997: 24-9. PMID 14715146 DOI: 10.1016/j.brainres.2003.08.066  1
2004 Hebeisen JC, Cox BM. The effect of HIP processing on the properties of A356 T6 cast aluminum steering knuckles Sae Technical Papers. DOI: 10.4271/2004-01-1027  0.01
2004 Hebeisen JC, Cox BM, Rampulla B. HIP of aluminum castings Advanced Materials and Processes. 162: 38-40.  0.01
2003 Witta J, Buzas B, Cox BM. Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex. Journal of Neurotrauma. 20: 523-32. PMID 12906737 DOI: 10.1089/089771503767168456  1
2002 Buzas B, Rosenberger J, Kim KW, Cox BM. Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture. Glia. 39: 237-46. PMID 12203390 DOI: 10.1002/glia.10106  1
2001 Romualdi P, D'Addario C, Ferri S, Cox BM, Izenwasser S. Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. European Journal of Pharmacology. 413: 207-12. PMID 11226394 DOI: 10.1016/S0014-2999(01)00776-2  1
2000 Chalecka-Franaszek E, Weems HB, Crowder AT, Cox BM, Côté TE. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3). Journal of Neurochemistry. 74: 1068-78. PMID 10693938 DOI: 10.1046/j.1471-4159.2000.0741068.x  1
1999 Buzas B, Symes AJ, Cox BM. Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. Journal of Neurochemistry. 72: 1882-9. PMID 10217264 DOI: 10.1046/j.1471-4159.1999.0721882.x  1
1998 Winkler A, Búzás B, Siems WE, Heder G, Cox BM. Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains. Alcoholism, Clinical and Experimental Research. 22: 1262-71. PMID 9756041  1
1998 Buzas B, Rosenberger J, Cox BM. Activity and cyclic AMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. Journal of Neurochemistry. 71: 556-63. PMID 9681445  1
1998 Azaryan AV, Clock BJ, Rosenberger JG, Cox BM. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Canadian Journal of Physiology and Pharmacology. 76: 278-83. PMID 9673791 DOI: 10.1139/cjpp-76-3-278  1
1998 Buzas B, Rosenberger J, Cox BM. Ca2+/calmodulin-dependent transcriptional activation of delta-opioid receptor gene expression induced by membrane depolarization in NG108-15 cells. Journal of Neurochemistry. 70: 105-12. PMID 9422352  1
1997 Noble F, Cox BM. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. The Journal of Pharmacology and Experimental Therapeutics. 283: 557-65. PMID 9353370  1
1997 Phillips JB, Cox BM. Release of endogenous glutamate and gamma-aminobutyric acid from rat striatal tissue slices measured by an improved method of high performance liquid chromatography with electrochemical detection. Journal of Neuroscience Methods. 75: 207-14. PMID 9288654 DOI: 10.1016/S0165-0270(97)00074-5  1
1997 Cox BM. Testing the power of prayer. Science (New York, N.Y.). 276: 1630-1. PMID 9206821  1
1997 Búzás B, Cox BM. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience. 76: 479-89. PMID 9015332 DOI: 10.1016/S0306-4522(96)00242-4  1
1997 Buzas B, Rosenberger J, Cox BM. Regulation of delta-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway. Journal of Neurochemistry. 68: 610-5. PMID 9003047  1
1997 Azaryan AV, Clock BJ, Cox BM. Activation of both D1 and D2 dopamine receptors is involved in the increased expression of mu opioid receptor gene in nucleus accumbens following dopamine agonist administration Faseb Journal. 11: A211.  1
1996 Azaryan AV, Clock BJ, Cox BM. Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation. Neurochemical Research. 21: 1411-5. PMID 8947931  1
1996 Buzas B, Rosenberger J, Cox BM. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport. 7: 1505-8. PMID 8856708  1
1996 Izenwasser S, Heller B, Cox BM. Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. European Journal of Pharmacology. 297: 187-91. PMID 8851182  1
1996 Izenwasser S, Newman AH, Cox BM, Katz JL. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. European Journal of Pharmacology. 297: 9-17. PMID 8851160 DOI: 10.1016/0014-2999(95)00696-6  1
1996 Romualdi P, Donatini A, Izenwasser S, Cox BM, Ferri S. Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen. Brain Research. Molecular Brain Research. 40: 153-6. PMID 8840025 DOI: 10.1016/0169-328X(96)00091-5  1
1996 Noble F, Cox BM. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. British Journal of Pharmacology. 117: 161-9. PMID 8825358  1
1996 Tang T, Stevens BA, Cox BM. Opioid regulation of intracellular free calcium in cultured mouse dorsal root ganglion neurons. Journal of Neuroscience Research. 44: 338-43. PMID 8739152 DOI: 10.1002/(SICI)1097-4547(19960515)44:4<338::AID-JNR4>3.0.CO;2-D  1
1996 Noble F, Cox BM. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Brain Research. 716: 107-17. PMID 8738226 DOI: 10.1016/0006-8993(96)00005-4  1
1996 Azaryan AV, Coughlin LJ, Búzás B, Clock BJ, Cox BM. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. Journal of Neurochemistry. 66: 443-8. PMID 8592112  1
1996 Phillips JB, Cox BM. An improved method of measuring glutamate and gaba released from rat brain tissue using high performance liquid chromatography (hplc) with electrochemical detection Faseb Journal. 10: A159.  1
1996 Azarvan AV, Clock BJ, Cox BM. Transient upregulation of mu opioid receptor mRNA in nucleus accumbens during chronic cocaine administration Faseb Journal. 10: A448.  1
1995 Noble F, Cox BM. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. Journal of Neurochemistry. 65: 125-33. PMID 7790855  1
1995 Tang T, Kiang JG, Côté TE, Cox BM. Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells. Molecular Pharmacology. 48: 189-93. PMID 7651350  1
1995 Tang T, Kiang JG, Cote T, Cox BM. Opioid-induced increase in [Ca2+]i in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells is mediated through G protein-coupled delta-opioid receptors and desensitized by chronic exposure to opioid. Journal of Neurochemistry. 65: 1612-21. PMID 7561856  1
1994 Búzás B, Izenwasser S, Portoghese PS, Cox BM. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sciences. 54: PL101-6. PMID 8309345 DOI: 10.1016/0024-3205(94)00412-9  1
1994 Tang T, Kiang JG, Cox BM. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells. The Journal of Pharmacology and Experimental Therapeutics. 270: 40-6. PMID 8035339  1
1994 Grimm LJ, Clock BJ, Cox BM. Comparison of the distribution of mu and delta opiate receptor mRNAs in rat and mouse brain by in situ hybridization Regulatory Peptides. 54: 111-112. DOI: 10.1016/0167-0115(94)90414-6  1
1994 Cox BM. Opiate Drug Tolerance: An introduction Regulatory Peptides. 54: 71-72. DOI: 10.1016/0167-0115(94)90394-8  1
1994 Búzás B, Cox BM. Competitive PCR assay for quantitation of mu and delta opioid receptor messenger-RNA levels in small tissue samples Regulatory Peptides. 54: 35-36. DOI: 10.1016/0167-0115(94)90376-X  1
1993 Izenwasser S, Rosenberger JG, Cox BM. The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: significance of assay procedures. Life Sciences. 52: PL141-5. PMID 8464332 DOI: 10.1016/0024-3205(93)90179-7  1
1993 Unterwald EM, Cox BM, Kreek MJ, Cote TE, Izenwasser S. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse (New York, N.Y.). 15: 33-8. PMID 8310423 DOI: 10.1002/syn.890150104  1
1993 Kim KW, Cox BM. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity. The Journal of Pharmacology and Experimental Therapeutics. 267: 1153-60. PMID 8263776  1
1993 Izenwasser S, Búzás B, Cox BM. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics. 267: 145-52. PMID 7901389  1
1993 Izenwasser S, Unterwald EM, Cote TE, Cox BM, Kreek MJ. Repeated, daily cocaine administration produces changes in basal and opioid-regulated adenylyl cyclase activity in rat caudate-putamen and nucleus accubens Nida Research Monograph Series. 392.  1
1992 Izenwasser S, Rosenberger JG, Cox BM. Inhibition of [3H]dopamine and [3H]serotonin uptake by cocaine: comparison between chopped tissue slices and synaptosomes. Life Sciences. 50: 541-7. PMID 1736024 DOI: 10.1016/0024-3205(92)90365-V  1
1992 Izenwasser S, Cox BM. Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments. Brain Research. 573: 119-25. PMID 1576529 DOI: 10.1016/0006-8993(92)90120-X  1
1992 Jacocks HM, Cox BM. Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. The Journal of Pharmacology and Experimental Therapeutics. 262: 356-64. PMID 1352552  1
1991 Izenwasser S, Jacocks HM, Rosenberger JG, Cox BM. Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum. Journal of Neurochemistry. 56: 603-10. PMID 1988558  1
1991 Jacocks HM, Izenwasser S, Werling LL, Cox BM. Comparison of dopamine uptake and release in vitro in sheep and rat striatum. Life Sciences. 49: 481-8. PMID 1830633 DOI: 10.1016/0024-3205(91)90064-I  1
1990 Izenwasser S, Cox BM. Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Research. 531: 338-41. PMID 2289133 DOI: 10.1016/0006-8993(90)90797-F  1
1990 Romualdi P, Lesa G, Cox BM, Ferri S. Distribution and characterization of VIP-related peptides in the rat spinal cord. Neuropeptides. 16: 219-25. PMID 2274116 DOI: 10.1016/0143-4179(90)90066-8  1
1990 Izenwasser S, Werling LL, Cox BM. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Research. 520: 303-9. PMID 2145054 DOI: 10.1016/0006-8993(90)91719-W  1
1990 Izenwasser S, Werling LL, Rosenberger JG, Cox BM. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways. Neuropharmacology. 29: 1017-24. PMID 2087254 DOI: 10.1016/0028-3908(90)90107-3  1
1990 Izenwasser S, Jacocks HM, Cox BM. Effect of (-) and (+) nicotine of [3H]DA uptake and release in rat striatum. Nida Research Monograph. 105: 330. PMID 1678868  1
1990 Werling LL, McMahon PN, Cox BM. A comparison of kappa opioid-, sigma-, and phencyclidine (PCP)-receptor regulation of dopamine release from striatal slices European Journal of Pharmacology. 183: 982-983. DOI: 10.1016/0014-2999(90)92826-5  1
1989 Romualdi P, Rosenberger JG, Gozzini L, Cox BM. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat. Peptides. 10: 621-6. PMID 2780421 DOI: 10.1016/0196-9781(89)90153-8  1
1989 Izenwasser S, Werling LL, Cox BM. Binding of [3H]GBR 12935 in the striatum, medial prefrontal cortex, nucleus accumbens and olfactory tubercle of rat. Nida Research Monograph. 95: 341-2. PMID 2640988  1
1989 Puttfarcken PS, Cox BM. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sciences. 45: 1937-42. PMID 2557508 DOI: 10.1016/0024-3205(89)90548-1  1
1989 Werling LL, McMahon PN, Cox BM. Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices. Naunyn-Schmiedeberg's Archives of Pharmacology. 339: 509-13. PMID 2549429 DOI: 10.1007/BF00167253  1
1989 Werling LL, McMahon PN, Cox BM. Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proceedings of the National Academy of Sciences of the United States of America. 86: 6393-7. PMID 2548212  1
1989 Werling LL, McMahon PN, Portoghese PS, Takemori AE, Cox BM. Selective opioid antagonist effects on opioid-induced inhibition of release of norepinephrine in guinea pig cortex. Neuropharmacology. 28: 103-7. PMID 2541364 DOI: 10.1016/0028-3908(89)90044-0  1
1988 Werling LL, McMahon PN, Cox BM. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. The Journal of Pharmacology and Experimental Therapeutics. 247: 1103-6. PMID 2849659  1
1988 Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. The Journal of Pharmacology and Experimental Therapeutics. 246: 282-6. PMID 2839666  1
1988 Puttfarcken PS, Werling LL, Cox BM. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Molecular Pharmacology. 33: 520-7. PMID 2835651  1
1988 Werling LL, Puttfarcken PS, Cox BM. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. Molecular Pharmacology. 33: 423-31. PMID 2833686  1
1988 Romualdi P, Cox BM, Ferri S. Evidence for the presence of VIP 22-28 heptapeptide in rat brain cortex Pharmacological Research Communications. 20: 35-36. DOI: 10.1016/S0031-6989(88)80628-3  1
1988 Romualdi P, Ferri S, Schoenberg DR, Cox BM. Prodynorphin gene expression in rat brain by "in situ" hybridization Pharmacological Research Communications. 20: 330.  1
1987 Cox BM, Rosenberger JG, Douglass J. Chromatographic characterization of dynorphin and [Leu5]enkephalin immunoreactivity in guinea pig and rat testis. Regulatory Peptides. 19: 1-12. PMID 2891155 DOI: 10.1016/0167-0115(87)90069-3  1
1987 Douglass J, Cox B, Quinn B, Civelli O, Herbert E. Expression of the prodynorphin gene in male and female mammalian reproductive tissues. Endocrinology. 120: 707-13. PMID 2879723 DOI: 10.1210/endo-120-2-707  1
1987 Werling LL, Brown SR, Cox BM. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology. 26: 987-96. PMID 2821438 DOI: 10.1016/0028-3908(87)90077-3  1
1986 Cox BM, Chavkin C. Properties of receptors mediating opioid effects: discrimination of receptor types. Nida Research Monograph. 71: 1-18. PMID 3025728  1
1986 Cox BM, Werling LL, Zarr G. Regulation of agonist binding to opioid receptor types of sodium and GTP: relevance to receptor function. Nida Research Monograph. 70: 175-91. PMID 3020422  1
1986 Zarr GD, Werling LL, Brown SR, Cox BM. Opioid ligand binding sites in the spinal cord of the guinea-pig. Neuropharmacology. 25: 471-80. PMID 3016586 DOI: 10.1016/0028-3908(86)90170-X  1
1986 Werling LL, Brown SR, Puttfarcken P, Cox BM. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Molecular Pharmacology. 30: 90-5. PMID 3016504  1
1986 Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Molecular Pharmacology. 30: 81-9. PMID 3016503  1
1986 Molineaux CJ, Hassen AH, Rosenberger JG, Cox BM. Response of rat pituitary anterior lobe prodynorphin products to changes in gonadal steroid environment. Endocrinology. 119: 2297-305. PMID 2876888 DOI: 10.1210/endo-119-5-2297  1
1986 Werling LL, Brown SR, Cox BM. Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices. Nida Research Monograph. 75: 587-90. PMID 2829006  1
1985 Werling LL, Zarr GD, Brown SR, Cox BM. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. The Journal of Pharmacology and Experimental Therapeutics. 233: 722-8. PMID 2989494  1
1985 Feuerstein G, Molineaux CJ, Rosenberger JG, Zerbe RL, Cox BM, Faden AI. Hemorrhagic shock and the central vasopressin and opioid peptide system of rats. The American Journal of Physiology. 249: E244-50. PMID 2863984  1
1985 Faden AI, Molineaux CJ, Rosenberger JG, Jacobs TP, Cox BM. Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regulatory Peptides. 11: 35-41. PMID 2861626 DOI: 10.1016/0167-0115(85)90029-1  1
1985 Faden AI, Molineaux CJ, Rosenberger JG, Jacobs TP, Cox BM. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury. Annals of Neurology. 17: 386-90. PMID 2860844 DOI: 10.1002/ana.410170414  1
1985 Cox BM, Molineaux CJ, Jacobs TP, Rosenberger JG, Faden AI. Effects of traumatic injury on dynorphin immunoreactivity in spinal cord. Neuropeptides. 5: 571-4. PMID 2860614 DOI: 10.1016/0143-4179(85)90082-4  1
1984 Cox BM, Goldstein A, Nelson WT. Nicotine self-administration in rats. British Journal of Pharmacology. 83: 49-55. PMID 6487896  1
1984 Feuerstein G, Molineaux CJ, Rosenberger JG, Zerbe RL, Cox BM, Faden AI. Effect of hemorrhage on vasopressin, dynorphin A, and leu5-enkephalin in the hypothalamo-pituitary system of the rat. Clinical and Experimental Hypertension. Part a, Theory and Practice. 6: 1973-6. PMID 6152409 DOI: 10.3109/10641968409046111  1
1984 Molineaux CJ, Rosenberger JG, Cox BM. Subcellular distribution of opioid peptides in rat hypothalamus and pituitary. Journal of Neurochemistry. 43: 1616-23. PMID 6149267  1
1984 Werling LL, Brown S, Cox BM. The sensitivity of opioid receptor types to regulation by sodium and GTP. Neuropeptides. 5: 137-40. PMID 6099482 DOI: 10.1016/0143-4179(84)90046-5  1
1983 Whitnall MH, Gainer H, Cox BM, Molineaux CJ. Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary. Science (New York, N.Y.). 222: 1137-9. PMID 6648526  1
1983 Feuerstein G, Molineaux CJ, Rosenberger JG, Faden AI, Cox BM. Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats. Peptides. 4: 225-9. PMID 6622288 DOI: 10.1016/0196-9781(83)90119-5  1
1983 Cox BM, Chavkin C. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. Molecular Pharmacology. 23: 36-43. PMID 6135144  1
1982 Cox BM, Baer ER, Goldstein A. Dynorphin immunoreactivity in pituitary. Advances in Biochemical Psychopharmacology. 33: 43-50. PMID 6127005  1
1981 Nelson WL, Sneed CK, Giacomini KM, Giacomini JC, Stauss J, Blaschke TF, Cox BM. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide. Journal of Medicinal Chemistry. 24: 614-7. PMID 7241519  1
1981 Dent RR, Guilleminault C, Albert LH, Posner BI, Cox BM, Goldstein A. Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. The Journal of Clinical Endocrinology and Metabolism. 52: 942-7. PMID 6262357 DOI: 10.1210/jcem-52-5-942  1
1981 Botticelli LJ, Cox BM, Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 78: 7783-6. PMID 6121324  1
1980 Cox BM, Leslie FM, Dunlap CE. The use of ascorbate as a probe of opioid receptor structure: evidence for two independent mechanisms of receptor destruction by ascorbate. Journal of Receptor Research. 1: 329-54. PMID 6271956 DOI: 10.3109/10799898009044104  1
1980 Leslie FM, Dunlap CE, Cox BM. Ascorbate decreases ligand binding to neurotransmitter receptors. Journal of Neurochemistry. 34: 219-21. PMID 6256473  1
1980 Cox BM, Leslie FM, Chavkin C. Characteristics of peptide and alkaloid opiate binding sites in brain and peripheral tissues. Advances in Biochemical Psychopharmacology. 22: 353-62. PMID 6249080  1
1980 Leslie FM, Chavkin C, Cox BM. Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. The Journal of Pharmacology and Experimental Therapeutics. 214: 395-402. PMID 6248635  1
1980 Cox BM, Ghazarossian VE, Goldstein A. Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neuroscience Letters. 20: 85-8. PMID 6133255  1
1979 Baizman ER, Cox BM, Osman OH, Goldstein A. Experimental alterations of endorphin levels in rat pituitary. Neuroendocrinology. 28: 402-14. PMID 572491  1
1979 Chavkin C, Cox BM, Goldstein A. Stereospecific opiate binding in bovine adrenal medulla. Molecular Pharmacology. 15: 751-3. PMID 226864  1
1979 Cox BM, Ross M, Goldstein A, Palmour RM. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin. Brain Research. 165: 311-9. PMID 217494 DOI: 10.1016/0006-8993(79)90562-6  1
1979 Dunlap CE, Leslie FM, Rado M, Cox BM. Ascorbate destruction of opiate stereospecific binding in guinea pig brain homogenate. Molecular Pharmacology. 16: 105-19. PMID 39241  1
1978 Gentleman S, Lowney LI, Cox BM, Goldstein A. Rapid purification of beta-endorphin by high-performance liquid chromatography. Journal of Chromatography. 153: 274-8. PMID 659560  1
1978 Baizman ER, Cox BM. Endorphin in rat pituitary glands: its distribution within the gland, and age related changes in gland content in male and female rats. Life Sciences. 22: 519-26. PMID 625196  0.32
1978 Ross M, Ghazarossian V, Cox BM, Goldstein A. Radioimmunoassays for beta-endorphin: comparison of properties of two antisera. Life Sciences. 22: 1123-30. PMID 566365  1
1978 Cox BM, Baizman ER, Su TP, Osman OH, Goldstein A. Further studies on the nature and functions of pituitary endorphins. Advances in Biochemical Psychopharmacology. 18: 183-9. PMID 565577  1
1977 Goldstein A, Cox BM. Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology. 2: 11-6. PMID 905473  1
1977 Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9  1
1977 Goldstein A, Cox BM, Klee WA, Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 265: 362-3. PMID 189215 DOI: 10.1038/265362a0  1
1976 Cox BM, Goldstein A, Hi CH. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences of the United States of America. 73: 1821-3. PMID 1064855  1
1976 Opheim KE, Cox BM. Stereospecific interaction of the quaternized opiate, N-methyllevorphanol, with opiate receptors. Journal of Medicinal Chemistry. 19: 857-8. PMID 950661  0.52
1976 Cox BM, Gentleman S, Su TP, Goldstein A. Further characterization of morphine-like peptides (endorphins) from pituitary. Brain Research. 115: 285-96. PMID 10049  1
1975 Goldstein A, Goldstein JS, Cox BM. A synthetic peptide with morphine-like pharmacologic action. Life Sciences. 17: 1643-54. PMID 1207378 DOI: 10.1016/0024-3205(75)90109-5  1
1975 Teschemacher H, Opheim KE, Cox BM, Goldstein A. A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sciences. 16: 1771-5. PMID 1171343  1
1975 Cox BM, Opheim KE, Teschemacher H, Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sciences. 16: 1777-82. PMID 1152601  1
1970 Cox BM, Osman OH. Inhibition of the development of tolerance to morphine in rats by drugs which inhibit ribonucleic acid or protein synthesis. British Journal of Pharmacology. 38: 157-70. PMID 5413284  0.32
1969 Cox BM, Osman OH. The role of protein synthesis inhibition in the prevention of morphine tolerance. British Journal of Pharmacology. 35: P373-4. PMID 4180116  0.32
1968 Cox BM, Ginsburg M, Osman OH. Acute tolerance to narcotic analgesic drugs in rats. British Journal of Pharmacology and Chemotherapy. 33: 245-56. PMID 5664145  0.32
Show low-probability matches.